211 related articles for article (PubMed ID: 9224903)
1. Serotonin syndrome and drug combinations: focus on MAOI and RIMA.
Hilton SE; Maradit H; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):113-9. PubMed ID: 9224903
[TBL] [Abstract][Full Text] [Related]
2. Isolated venlafaxine-induced serotonin syndrome.
Kolecki P
J Emerg Med; 1997; 15(4):491-3. PubMed ID: 9279702
[TBL] [Abstract][Full Text] [Related]
3. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
4. [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
König F; Löble M; Wolfersdorf M
Nervenarzt; 1996 May; 67(5):407-12. PubMed ID: 9005353
[TBL] [Abstract][Full Text] [Related]
5. MAOIs to RIMAs in anaesthesia--a literature review.
Hill S; Yau K; Whitwam J
Psychopharmacology (Berl); 1992; 106 Suppl():S43-5. PubMed ID: 1546140
[TBL] [Abstract][Full Text] [Related]
6. Serotonin syndrome with moclobemide-fluoxetine combination.
Benazzi F
Pharmacopsychiatry; 1996 Jul; 29(4):162. PubMed ID: 8858717
[No Abstract] [Full Text] [Related]
7. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review.
Lane R; Baldwin D
J Clin Psychopharmacol; 1997 Jun; 17(3):208-21. PubMed ID: 9169967
[TBL] [Abstract][Full Text] [Related]
8. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
Norman TR; Burrows GD
Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Lotufo-Neto F; Trivedi M; Thase ME
Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
[TBL] [Abstract][Full Text] [Related]
10. Serotonin syndrome--clomipramine too soon after moclobemide?
Gillman PK
Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136
[No Abstract] [Full Text] [Related]
11. Serotonin syndrome.
Ivanusa Z; Hećimović H; Demarin V
Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):209-12. PubMed ID: 9297715
[TBL] [Abstract][Full Text] [Related]
12. Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels.
Elli C; Novella A; Pasina L
Eur J Clin Pharmacol; 2024 Feb; 80(2):231-237. PubMed ID: 38032391
[TBL] [Abstract][Full Text] [Related]
13. The serotonin syndrome.
Bijl D
Neth J Med; 2004 Oct; 62(9):309-13. PubMed ID: 15635814
[TBL] [Abstract][Full Text] [Related]
14. Clinical overview on moclobemide.
Tiller JW
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):703-12. PubMed ID: 8255982
[TBL] [Abstract][Full Text] [Related]
15. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
16. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association.
François B; Marquet P; Desachy A; Roustan J; Lachatre G; Gastinne H
Intensive Care Med; 1997 Jan; 23(1):122-4. PubMed ID: 9037653
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
Nair NP; Ahmed SK; Kin NM
J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.
Gillman PK
Br J Anaesth; 2005 Oct; 95(4):434-41. PubMed ID: 16051647
[TBL] [Abstract][Full Text] [Related]
19. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
[TBL] [Abstract][Full Text] [Related]
20. Serotonin syndrome in combined moclobemide and venlafaxine ingestion.
Roxanas MG; Machado JF
Med J Aust; 1998 May; 168(10):523-4. PubMed ID: 9631680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
